Loading...
The pleiotropic cardiovascular effects of dipeptidyl peptidase‐4 inhibitors
Patients with Type 2 diabetes have an excess risk for cardiovascular disease. One of the several approaches, included in the guidelines for the management of Type 2 diabetes, is based on dipeptidyl peptidase 4 (DPP‐4; also termed CD26) inhibitors, also called gliptins. Gliptins inhibit the degradati...
Saved in:
| Published in: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6046494/ https://ncbi.nlm.nih.gov/pubmed/29667232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13611 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|